Evaluation of Fenugreek (Trigonella foenum-graceum L.), Effects Seeds Extract on Insulin Resistance in Women with Polycystic Ovarian Syndrome

Maryam Hassanzadeh Bashtian, Seyed Ahmad Emami, Nezhat Mousavifar, Habib Allah Esmaily, Mahmoud Mahmoudi, Amir Hooshang Mohammad Poor, Maryam Hassanzadeh Bashtian, Seyed Ahmad Emami, Nezhat Mousavifar, Habib Allah Esmaily, Mahmoud Mahmoudi, Amir Hooshang Mohammad Poor

Abstract

PCOS (Polycystic Ovarian Syndrome) is associated with insulin resistance, obesity and disorders of lipid metabolism as well as infertility. Fenugreek seeds extract is successfully used in lowering blood glucose. Metformin has also the same effect but in a different way. The aim of this study was the assessment of fenugreek effects on insulin resistance in women with PCOS. This was a prospective randomized, double-blind, placebo-controlled trial. The study was conducted at the Montaserieh Hospital in Mashhad University of Medical Sciences, Mashhad, Khorasan Razavi Province, Iran. The patient population included 58 oligo-anovulatory PCOS women with typical ovaries. Women were randomly allocated to receive hydroalcoholic extract of fenugreek seeds in capsules with metformin (n = 30) or placebo capsules with metformin (n = 28) and were assessed before and every 4 weeks within a treatment period of 8 weeks. Menstrual disturbance and metabolic parameters (markers of insulin resistance and hormonal parameters) were measured. Insulin resistance based on HOMA-IR (homeostasis model assessment for insulin resistance) model was not significantly different between two groups. Ultrasound scans were performed before and at the end of 8 weeks treatment with significant decrease in PAO (polycystic appearing ovaries) in group 1 (p = 0/01). Adjuvant therapy to the fenugreek seeds extract (with metformin) in PCOS women improved the sonographic results and menstrual cyclicity.

Keywords: Fenugreek; Insulin resistance; Metformin; Oligo-Amenorrhea; PCOS.

References

    1. Galluzzo A, Calogero Amato M, Giordano C. Insulin resistance and polycystic ovary syndrome. Nutr. Metab. Cardiovas Dis. 2008;18:511–518.
    1. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF. Androgen Excess Society: Position statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J. Clin. Endocrinol. Metab. 2006;91:4237–45.
    1. Eisenhardt S, Schwarzmann N, Henschel V, Germeyer A, Von Wolf M, Hamann A, Strowitzki T. Early effects of Metformin in women with polycystic ovary syndrome: A prospective randomized, double-blind, placebo-controlled trial. J. Clin. Endocrinol. Metab. 2006;91:946–952.
    1. Diamanti Kandarakis E, Kourli C, Tsianateli T, Bergiele A. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur. J. Endocrinol. 1998;138:269–294.
    1. Eidi A, Eidi M, Sokhteh M. Effect of fenugreek (Trigonella foenum-graecum L) seeds on serum parameters in normal and streptozotocin-induced diabetic rats. Nutrition Research. 2007;27:728–733.
    1. Vijayakumar MV, singh S. chhipa RR , Bhat MK. The hypoglycaemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signalling pathway. Br. J. Pharmacol. 2005;146:41–48.
    1. Al-Habori M, Raman A. Antidiabetic and hypocholestrolaemic effects of fenugreek. Phytother. Res. 1998;12:233–242.
    1. Shamsa F, Reza Zadeh S, Shamsa H, Abdi Kh. A quantitative investigation on some toxic and non-toxic metals in popular medicinal herbs in Iranian market. Iranian J. Pharm. Res. 2009;8:95–99.
    1. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum. Reprod. 2004;19:41–47.
    1. Kousta E, Tolis G, Franks S. Polycystic ovary syndrome. Revised diagnostic criteria and long – term health consequences. Hormones (Athens Greece) 2005;4:133–47.
    1. Feriman D, Gallwey JD. Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 1961;21:1440–8.
    1. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J. Clin. Endocrinol. Metab. 2000;85:4426–4433.
    1. Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN. The threshold value for insulin resistance (HOMA-IR) in an admixtured population. IR in the brazilian metabolic syndrome study. Res. Clin. Pract. 2006;72:219–220.
    1. Quon MJ. Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. J. Clin. Endocrinol. Metab. 2001;86:4615–4617.
    1. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Moroles PA, Slem MP. Prospective analysis of the insulin resistance syndrome (Syndrome X) Diabetes. 1992;41:715–22.
    1. Lord JM, Flight IHK, Norman RJ. Metformin in polycystic ovary syndrome: Systematic review and meta-analysis. Br. Med. J. 2003;327:951–953.
    1. Fleming R, Hopkinson ZE, Wallace Am, Greer IA, Sattar N. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J. Clin. Endocrinol. Metab. 2002;87:569–74.
    1. Sharma RD. Effect of Fenugreek seeds and leaves on blood glucose and serum insulin response human subjects. Nutrition Res. 1986;12:1353–1364.
    1. Gupta A, Gupta R, Lal B. Effect of Trigonella Foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in Type 2 diabetes mellitus: A double Blind Placebo controlled study. J. Assoc. Physicians of India. 2001;45:1057–1061.
    1. Puri D, Prabhy KM, Murthy PS. Mechanism of action of a hypoglycemic principle isolated from fenugreek seeds. Indian J. Physiol. Pharmacol. 2002;46:457–62.
    1. Basch E, Ulbricht C, Kuo G, Szapary P, Smith M. Therapeutic applications of fenugreek. Altern. Med. Rev. 2003;8:20–27.
    1. Patti G, Shane –Mc Whorter L. Dietary supplements in the management of diabetes: potential risks and benefits. J. Am. Diet. Assoc. 2008;108:S59–S65.
    1. Priwany IR, Yates RW, Cameron IT and Fleming R. Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhea. Hum. Reprod. 1999;14:2963–8.
    1. Harborne L, Fleming R, Lyall H, Sattar N, Norman J. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2003;88:4116–4123.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe